OVIT Insider Trading Activity and SEC Form 4 Filings
OVIT insider trading summary
No open-market insider purchases or sales of Oncovista Innovative Therapies, Inc (OVIT) have been reported on SEC Form 4 in the past 12 months.
Latest OVIT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 30, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $1K (2,000 @ $0.61) |
| Jun 30, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $3K (5,000 @ $0.55) |
| Jun 30, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $9K (14,000 @ $0.65) |
| Jun 30, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $540 (1,000 @ $0.54) |
| Jun 29, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $110 (200 @ $0.55) |
| Jun 28, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $1K (2,500 @ $0.56) |
| Jun 28, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $7K (11,500 @ $0.58) |
| Jun 28, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $570 (1,000 @ $0.57) |
| Mar 8, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $6K (14,500 @ $0.44) |
| Mar 8, 2011 | Alexander L Weis | President, CEO, CFO, Secretary | Buy | $2K (5,000 @ $0.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.